25 related articles for article (PubMed ID: 15742553)
1. Biomolecule gradient in micropatterned nanofibrous scaffold for spatiotemporal release.
Bonani W; Motta A; Migliaresi C; Tan W
Langmuir; 2012 Sep; 28(38):13675-87. PubMed ID: 22950580
[TBL] [Abstract][Full Text] [Related]
2. Improved biocompatibility of novel poly(L-lactic acid)/β-tricalcium phosphate scaffolds prepared by an organic solvent-free method.
Zhao XF; Li XD; Kang YQ; Yuan Q
Int J Nanomedicine; 2011; 6():1385-90. PubMed ID: 21760732
[TBL] [Abstract][Full Text] [Related]
3. Drug releasing systems in cardiovascular tissue engineering.
Spadaccio C; Chello M; Trombetta M; Rainer A; Toyoda Y; Genovese JA
J Cell Mol Med; 2009 Mar; 13(3):422-39. PubMed ID: 19379142
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable elastomeric scaffolds with basic fibroblast growth factor release.
Guan J; Stankus JJ; Wagner WR
J Control Release; 2007 Jul; 120(1-2):70-8. PubMed ID: 17509717
[TBL] [Abstract][Full Text] [Related]
5. Bioencapsulation within synthetic polymers (Part 2): non-sol-gel protein-polymer biocomposites.
Gill I; Ballesteros A
Trends Biotechnol; 2000 Nov; 18(11):469-79. PubMed ID: 11058788
[TBL] [Abstract][Full Text] [Related]
6. Active growth factor delivery from poly(D,L-lactide-co-glycolide) foams prepared in supercritical CO(2).
Hile DD; Amirpour ML; Akgerman A; Pishko MV
J Control Release; 2000 May; 66(2-3):177-85. PubMed ID: 10742578
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
Lu L; Peter SJ; Lyman MD; Lai HL; Leite SM; Tamada JA; Uyama S; Vacanti JP; Langer R; Mikos AG
Biomaterials; 2000 Sep; 21(18):1837-45. PubMed ID: 10919687
[TBL] [Abstract][Full Text] [Related]
8. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent.
Young TJ; Johnston KP; Mishima K; Tanaka H
J Pharm Sci; 1999 Jun; 88(6):640-50. PubMed ID: 10350502
[TBL] [Abstract][Full Text] [Related]
9. Generation of porous microcellular 85/15 poly (DL-lactide-co-glycolide) foams for biomedical applications.
Singh L; Kumar V; Ratner BD
Biomaterials; 2004 Jun; 25(13):2611-7. PubMed ID: 14751747
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique. I: Evaluation of formulation variables on microspheres characteristics for brain delivery.
Arica B; Kaş HS; Orman MN; Hincal AA
J Microencapsul; 2002; 19(4):473-84. PubMed ID: 12396384
[TBL] [Abstract][Full Text] [Related]
11. Solvent-free protein encapsulation within biodegradable polymer foams.
Hile DD; Pishko MV
Drug Deliv; 2004; 11(5):287-93. PubMed ID: 15742553
[TBL] [Abstract][Full Text] [Related]
12. Application of supercritical antisolvent method in drug encapsulation: a review.
Kalani M; Yunus R
Int J Nanomedicine; 2011; 6():1429-42. PubMed ID: 21796245
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
